Evaluation of the Effectiveness of the Parkinson Specialized Teams Intervention

Exclusion Criteria

• •For the patient:
• •Patient with medically indicated dementia impairing comprehension and adherence, and/or with severe confusion or psycho-hallucinatory state;
• •Institutionalized or foster care patients;
• •Patients with a known severe and unstable general pathology that does not allow for patient follow-up;
• •Patients already included in another non-drug management trial;
• •Patients whose institutionalization is envisaged in the short term (within 6 months) or for whom a change of residence is envisaged in the short term and would not allow for follow-up assessments;
• •Patients under guardianship or unable to express consent
• •Primary caregiver not wishing to participate in the study or unable to be available for the planned study follow-up;
• •Presence of a primary caregiver with a known severe and unstable disease that does not allow for the conduct of the study;
• •Presence of a primary caregiver with a known cognitive or psychiatric disorder (chronic progressive psychosis) that does not allow for the proper conduct of the study.
• •Pregnant or breastfeeding woman.
• •For the caregiver:
• •Unable to follow the research interviews or questionnaires.
• •Primary caregiver not wishing to participate in the study or unable to be available for the planned study follow-up;
• •Primary caregiver with a known severe and unstable illness that does not allow for the proper conduct of the study;
• •Primary caregiver with known cognitive or psychiatric disorders (chronic progressive psychosis) that do not allow the study to be conducted properly.